Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Amazon
AMZN
|
$10.1B |
| 2 |
AbbVie
ABBV
|
$1.41B |
| 3 |
Shopify
SHOP
|
$1.09B |
| 4 |
Eli Lilly
LLY
|
$945M |
| 5 |
Exxon Mobil
XOM
|
$890M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$1.81B |
| 2 |
Deutsche Bank
DB
|
$1.49B |
| 3 |
Amgen
AMGN
|
$1.06B |
| 4 |
Charles Schwab
SCHW
|
$1.02B |
| 5 |
Broadcom
AVGO
|
$965M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Healthcare | 16.3% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Industrials | 10.89% |
| 5 | Financials | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Nike
NKE
$114B
| $290M | 0.09% | 2,841,613 -882,884 | -24% | -$90.2M |
|
177
Chubb
CB
$110B
| $280M | 0.09% | 1,426,514 +869,400 | +156% | +$171M |
|
178
Kimco Realty
KIM
$15.2B
| $279M | 0.09% | 14,105,157 +1,020,376 | +8% | +$20.2M |
|
179
Penumbra
PEN
$10.6B
| $276M | 0.09% | 2,212,361 -285,257 | -11% | -$35.5M |
|
180
Stanley Black & Decker
SWK
$11.5B
| $275M | 0.09% | 2,626,589 -429,093 | -14% | -$45M |
|
181
CubeSmart
CUBE
$9.33B
| $274M | 0.09% | 6,411,021 +3,777,484 | +143% | +$161M |
|
182
TELUS International
TIXT
$1.08B
| $270M | 0.08% | 10,754,539 +2,432,594 | +29% | +$61M |
|
183
Paycom
PAYC
$12.8B
| $269M | 0.08% | 961,285 -23,853 | -2% | -$6.68M |
|
184
Zimmer Biomet
ZBH
$21B
| $266M | 0.08% | 2,531,394 -809,014 | -24% | -$85M |
|
185
Sea Limited
SE
$110B
| $263M | 0.08% | 3,936,098 +14,040 | +0.4% | +$939K |
|
|
PXD
186
DELISTED
Pioneer Natural Resource Co.
PXD
| $260M | 0.08% | 1,166,855 -112,676 | -9% | -$25.1M |
|
187
American Electric Power
AEP
$59.4B
| $258M | 0.08% | 2,685,368 -3,433,785 | -56% | -$329M |
|
188
Monster Beverage
MNST
$60.9B
| $250M | 0.08% | 2,697,392 +1,130 | +0% | +$105K |
|
189
Nutrien
NTR
$28B
| $250M | 0.08% | 3,131,298 -964 | -0% | -$76.8K |
|
190
Nu Holdings
NU
$71.5B
| $246M | 0.08% | 65,857,366 +16,605,125 | +34% | +$62.1M |
|
191
SouthState
SSB
$10.3B
| $244M | 0.08% | 3,164,079 -887,207 | -22% | -$68.4M |
|
|
APTV.PRA
192
DELISTED
Aptiv PLC 5.50% Series A Mandatory Convertible Preferred Shares
APTV.PRA
| $242M | 0.08% | 2,299,808 +12 | +0% | +$1.27K |
|
193
GSK
GSK
$79.9B
| $242M | 0.08% | 5,567,697 -1,267 | -0% | -$55.2K |
|
194
Helen of Troy
HELE
$564M
| $242M | 0.08% | 1,491,137 +472 | +0% | +$76.7K |
|
195
CVS Health
CVS
$92.8B
| $240M | 0.07% | 2,595,246 +4,921 | +0.2% | +$456K |
|
196
Lam Research
LRCX
$127B
| $239M | 0.07% | 561,663 +231,868 | +70% | +$98.8M |
|
197
Air Products & Chemicals
APD
$65.5B
| $239M | 0.07% | 995,128 +226,154 | +29% | +$54.4M |
|
198
Xcel Energy
XEL
$42.8B
| $239M | 0.07% | 3,375,165 -893 | -0% | -$63.2K |
|
199
Sherwin-Williams
SHW
$91.2B
| $237M | 0.07% | 1,059,233 | – | – |
|
200
ZTO Express
ZTO
$14.6B
| $237M | 0.07% | 8,640,092 +3,223 | +0% | +$88.5K |
|